A Phase II Study of Envofolimab and BD0801 With/Without Chemotherapy in Patients With Advanced Solid Tumors
Clinical trial NCT05148195 · TERMINATED
Trial details
- NCT number
- NCT05148195
- Sponsor
- Jiangsu Simcere Pharmaceutical Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-22
- Primary completion
- 2023-07-26
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.